Table 2.
Characteristic | n | % |
---|---|---|
| ||
Enrollment location | ||
Abortion clinics | 1501 | 16.2 |
University or community clinics | 7755 | 83.8 |
| ||
Age (years) | ||
14–17 | 484 | 5.2 |
18–20 | 1547 | 16.7 |
21–25 | 3564 | 38.5 |
26–35 | 3026 | 32.7 |
36–45 | 635 | 6.9 |
| ||
Race | ||
Black | 4670 | 50.5 |
White | 3870 | 41.8 |
Other | 715 | 7.7 |
| ||
Hispanic ethnicity | 475 | 5.1 |
| ||
Education | ||
High school or less | 3205 | 34.6 |
Some college | 3902 | 42.2 |
College or more | 2146 | 23.2 |
| ||
Receiving public assistance* | 3442 | 37.2 |
| ||
Trouble paying basic expenses† | 3639 | 39.4 |
| ||
Insurance | ||
None | 3782 | 41.1 |
Private | 3957 | 43.1 |
Public | 1455 | 15.8 |
| ||
Parity | ||
0 | 4369 | 47.2 |
1 | 2279 | 24.6 |
2 | 1606 | 17.4 |
3 or more | 1002 | 10.8 |
| ||
Unintended pregnancies | ||
0 | 3413 | 36.9 |
1 | 2492 | 26.9 |
2 | 1551 | 16.8 |
3 or more | 1794 | 19.4 |
| ||
Ever had an abortion including at time of study enrollment | 3871 | 41.8 |
| ||
History of STI‡ | 3746 | 40.5 |
| ||
Baseline chosen method | ||
Levonorgestrel intrauterine device | 4261 | 46.0 |
Copper intrauterine device | 1101 | 11.9 |
Etonogestrel implant | 1566 | 16.9 |
Depot medroxyprogesterone acetate | 638 | 6.9 |
Oral contraceptive pill | 874 | 9.4 |
Contraceptive vaginal ring | 646 | 7.0 |
Contraceptive patch | 166 | 1.8 |
Natural family planning | 3 | <0.01 |
Diaphragm | 1 | <0.01 |
Current receipt of food stamps, Woman Infants and Children (WIC), welfare, or unemployment.
Transportation, housing, health or medical care, or food.
Self-reported of history of chlamydia, gonorrhea, syphilis, trichomoniasis, genital herpes, human papillomavirus or human immunodeficiency virus.
Some variables do not sum to total sample size due to unanswered survey items, missing data, or both.